Suspension of trading

Income Statement eFFECTOR Therapeutics, Inc. Deutsche Boerse AG

Stocks

LWK1

US28202V1089

Biotechnology & Medical Research

Market Closed - Deutsche Boerse AG 03:59:01 2024-06-24 EDT			5-day change	1st Jan Change
1.075 ^EUR	+0.47%		-8.12%	-88.97%

24-09-10	Tyra Biosciences Names Doug Warner Chief Medical Officer	MT
24-07-07	EFFECTOR Therapeutics, Inc.(OTCPK:EFTR) dropped from S&P TMI Index	CI

dd2f.Q5gCGePO2uSY8YpoS_aXt4pOIz6aUhsNloDLb0VGbsc.NuAyYLqFo5HvwMgELJHa8d0hRHz5B1BK3NqDXi0uJ6M53lJMiJaqif6bug

Published financial data: EFFECTOR THERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)
Revenues	-	42M	1.43M	3.55M	-
Total Revenues	-	42M	1.43M	3.55M	-
Cost of Goods Sold, Total	23.89M	21.83M	19.96M	23.31M	22.92M
Gross Profit	-23.89M	20.17M	-18.53M	-19.76M	-22.92M
Selling General & Admin Expenses, Total	4.72M	4.35M	13.37M	12.64M	10.92M
Other Operating Expenses, Total	4.72M	4.35M	13.37M	12.64M	10.92M
Operating Income	-28.6M	15.82M	-31.9M	-32.4M	-33.84M
Interest Expense, Total	-1.38M	-1.33M	-1.76M	-2.25M	-2.92M
Interest And Investment Income	239K	67K	6K	439K	972K
Net Interest Expenses	-1.14M	-1.27M	-1.76M	-1.81M	-1.95M
Other Non Operating Income (Expenses)	8K	9K	1.04M	-574K	-26K
EBT, Excl. Unusual Items	-29.74M	14.56M	-32.62M	-34.79M	-35.82M
Other Unusual Items	15.53M	-	48.42M	12.12M	6K
EBT, Incl. Unusual Items	-14.21M	14.56M	15.8M	-22.66M	-35.81M
Income Tax Expense	-	351K	-	-	-
Earnings From Continuing Operations	-14.21M	14.21M	15.8M	-22.66M	-35.81M
Net Income to Company	-14.21M	14.21M	15.8M	-22.66M	-35.81M
Minority Interest	-	-14.04M	-	-	-
Net Income - (IS)	-14.21M	166K	15.8M	-22.66M	-35.81M
Net Income to Common Incl Extra Items	-14.21M	166K	15.8M	-22.66M	-35.81M
Net Income to Common Excl. Extra Items	-14.21M	166K	15.8M	-22.66M	-35.81M
Per Share Items
Net EPS - Basic	-28.69	0.28	26.15	-13.76	-16.37
Basic EPS - Continuing Operations	-28.69	0.28	26.15	-13.76	-16.37
Basic Weighted Average Shares Outstanding	495K	584K	604K	1.65M	2.19M
Net EPS - Diluted	-28.75	0.27	11	-13.76	-16.37
Diluted EPS - Continuing Operations	-28.75	0.27	11	-13.76	-16.37
Diluted Weighted Average Shares Outstanding	495K	1.1M	1.44M	1.65M	2.19M
Normalized Basic EPS	-37.52	-8.46	-33.74	-13.2	-10.24
Normalized Diluted EPS	-37.52	-4.5	-14.16	-13.2	-10.24
Supplemental Items
EBITDA	-28.3M	15.98M	-31.87M	-32.35M	-33.73M
EBITA	-28.6M	15.82M	-31.9M	-32.4M	-33.84M
EBIT	-28.6M	15.82M	-31.9M	-32.4M	-33.84M
EBITDAR	-	-	-31.76M	-32.25M	-33.63M
Total Revenues (As Reported)	-	-	1.43M	-	-
Effective Tax Rate - (Ratio)	-	2.41	-	-	-
Normalized Net Income	-18.59M	-4.94M	-20.39M	-21.74M	-22.39M
Interest on Long-Term Debt	1.38M	1.33M	1.76M	2.25M	2.92M
Supplemental Operating Expense Items
General and Administrative Expenses	4.72M	4.35M	13.37M	12.64M	10.92M
Research And Development Expense From Footnotes	23.89M	21.83M	19.96M	23.31M	22.92M
Net Rental Expense, Total	-	-	116K	100K	100K
Imputed Operating Lease Interest Expense	-	-	99.58K	89.34K	114K
Imputed Operating Lease Depreciation	-	-	16.82K	10.66K	-14.4K
Stock-Based Comp., Other (Total)	646K	499K	8.66M	5.33M	4.6M
Total Stock-Based Compensation	646K	499K	8.66M	5.33M	4.6M

Fiscal Period: December	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)
Assets
Cash And Equivalents	3.43M	15.22M	49.7M	8.71M	14.88M
Short Term Investments	-	-	-	17.6M	3.5M
Total Cash And Short Term Investments	3.43M	15.22M	49.7M	26.31M	18.37M
Accounts Receivable, Total	-	-	100K	-	-
Other Receivables	-	-	-	27K	52K
Total Receivables	-	-	100K	27K	52K
Prepaid Expenses	845K	1.36M	3.09M	1.68M	1.42M
Total Current Assets	4.27M	16.58M	52.9M	28.01M	19.84M
Gross Property Plant And Equipment	3.65M	319K	461K	568K	517K
Accumulated Depreciation	-2.83M	-193K	-204K	-216K	-324K
Net Property Plant And Equipment	823K	126K	257K	352K	193K
Other Long-Term Assets, Total	-	-	903K	711K	513K
Total Assets	5.1M	16.7M	54.06M	29.08M	20.54M
Liabilities
Accounts Payable, Total	598K	347K	516K	1.49M	2.33M
Accrued Expenses, Total	2.65M	1.63M	3.07M	2.9M	2.92M
Short-term Borrowings	14.73M	12.85M	-	-	-
Current Portion of Long-Term Debt	-	-	-	20.16M	20.48M
Current Portion of Leases	514K	108K	44K	60K	60K
Current Income Taxes Payable	-	351K	351K	463K	-
Other Current Liabilities	442K	433K	-	-	-
Total Current Liabilities	18.93M	15.72M	3.98M	25.08M	25.8M
Long-Term Debt	-	-	19.86M	-	-
Long-Term Leases	-	-	126K	60K	-
Other Non Current Liabilities	-	-	12.81M	46K	543K
Total Liabilities	18.93M	15.72M	36.77M	25.18M	26.34M
Preferred Stock Convertible	133M	133M	-	-	-
Total Preferred Equity	133M	133M	-	-	-
Common Stock, Total	1K	1K	4K	4K	-
Additional Paid In Capital	3.85M	4.45M	138M	147M	174M
Retained Earnings	-151M	-137M	-121M	-144M	-179M
Comprehensive Income and Other	-	-	-	-18K	-
Total Common Equity	-147M	-132M	17.28M	3.9M	-5.8M
Total Equity	-13.84M	979K	17.28M	3.9M	-5.8M
Total Liabilities And Equity	5.1M	16.7M	54.06M	29.08M	20.54M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	495K	14.96M	1.66M	1.7M	3.69M
ECS Total Common Shares Outstanding	495K	14.96M	1.62M	1.67M	2.98M
Book Value / Share	-296.89	-8.84	10.7	2.34	-1.94
Tangible Book Value	-147M	-132M	17.28M	3.9M	-5.8M
Tangible Book Value Per Share	-296.89	-8.84	10.7	2.34	-1.94
Total Debt	15.24M	12.96M	20.03M	20.28M	20.54M
Net Debt	11.82M	-2.26M	-29.67M	-6.03M	2.18M
Debt Equivalent Oper. Leases	-	-	931K	800K	800K
Account Code - Inventory Valuation	-	3	3	3	3
Machinery, Total	2.09M	227K	221K	240K	262K
Full Time Employees	-	-	12	15	14
Part Time Employees	-	2	-	-	-

Fiscal Period: December	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)
Net Income	-14.21M	166K	15.8M	-22.66M	-35.81M
Depreciation & Amortization - CF	307K	160K	24K	53K	111K
Depreciation & Amortization, Total	307K	160K	24K	53K	111K
(Gain) Loss From Sale Of Asset	-16K	-324K	-	1K	-3K
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-37K	-473K
Stock-Based Compensation (CF)	646K	499K	8.66M	5.33M	4.6M
Other Operating Activities, Total	-15.4M	14.16M	-49.13M	-11.26M	346K
Change In Accounts Payable	-727K	-251K	155K	958K	855K
Change in Other Net Operating Assets	1.8M	-573K	-393K	1.72M	830K
Cash from Operations	-27.6M	13.84M	-24.89M	-25.9M	-29.55M
Capital Expenditure	-4K	-154K	-42K	-192K	-97K
Sale of Property, Plant, and Equipment	88K	-	607K	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-17.67M	14.58M
Cash from Investing	84K	-154K	565K	-17.86M	14.48M
Long-Term Debt Issued, Total	-	-	19.84M	-	-
Total Debt Issued	-	-	19.84M	-	-
Long-Term Debt Repaid, Total	-	-2M	-13.94M	-	-
Total Debt Repaid	-	-2M	-13.94M	-	-
Issuance of Common Stock	-	108K	52.91M	2.8M	21.23M
Repurchase of Common Stock	-86K	-	-	-	-
Issuance of Preferred Stock	20.42M	-	-	-	-
Other Financing Activities, Total	-93K	-	-	-37K	-
Cash from Financing	20.24M	-1.89M	58.81M	2.76M	21.23M
Net Change in Cash	-7.27M	11.79M	34.49M	-40.99M	6.17M
Supplemental Items
Cash Interest Paid	1.04M	975K	1.34M	1.82M	2.53M
Levered Free Cash Flow	-	8.12M	-13.06M	-14.05M	-17.73M
Unlevered Free Cash Flow	-	8.95M	-11.96M	-12.65M	-15.91M
Change In Net Working Capital	-	1.44M	662K	-2.41M	-633K
Net Debt Issued / Repaid	-	-2M	5.9M	-	-

Fiscal Period: December	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)
Profitability
Return on Assets	-	90.71	-56.35	-48.72	-85.26
Return on Total Capital	-	128.85	-77.79	-65.87	-108.68
Return On Equity %	-	-221.01	173.01	-214.02	3.77K
Return on Common Equity	-	-0.12	-27.48	-214.02	3.77K
Margin Analysis
Gross Profit Margin %	-	48.02	-1.3K	-556.15	-
SG&A Margin	-	10.35	935.03	355.84	-
EBITDA Margin %	-	38.05	-2.23K	-910.5	-
EBITA Margin %	-	37.66	-2.23K	-911.99	-
EBIT Margin %	-	37.66	-2.23K	-911.99	-
Income From Continuing Operations Margin %	-	33.84	1.1K	-637.91	-
Net Income Margin %	-	0.4	1.1K	-637.91	-
Net Avail. For Common Margin %	-	0.4	1.1K	-637.91	-
Normalized Net Income Margin	-	-11.77	-1.43K	-611.97	-
Levered Free Cash Flow Margin	-	19.33	-913.16	-395.55	-
Unlevered Free Cash Flow Margin	-	21.31	-836.06	-355.95	-
Asset Turnover
Asset Turnover	-	3.85	0.04	0.09	-
Fixed Assets Turnover	-	88.51	7.47	11.67	-
Short Term Liquidity
Current Ratio	0.23	1.05	13.3	1.12	0.77
Quick Ratio	0.18	0.97	12.52	1.05	0.71
Operating Cash Flow to Current Liabilities	-1.46	0.88	-6.26	-1.03	-1.15
Average Days Payable Outstanding	-	7.92	7.89	15.67	30.39
Long Term Solvency
Total Debt/Equity	-110.16	1.32K	115.89	520.56	-354.53
Total Debt / Total Capital	1.08K	92.98	53.68	83.89	139.29
LT Debt/Equity	-	-	115.63	1.54	-
Long-Term Debt / Total Capital	-	-	53.56	0.25	-
Total Liabilities / Total Assets	371.62	94.14	68.03	86.6	128.21
EBIT / Interest Expense	-20.71	11.87	-18.08	-14.39	-11.59
EBITDA / Interest Expense	-20.49	11.99	-18	-14.33	-11.52
(EBITDA - Capex) / Interest Expense	-20.49	11.87	-18.03	-14.41	-11.56
Total Debt / EBITDA	-0.54	0.81	-0.63	-0.63	-0.61
Net Debt / EBITDA	-0.42	-0.14	0.93	0.19	-0.06
Total Debt / (EBITDA - Capex)	-0.54	0.82	-0.63	-0.63	-0.61
Net Debt / (EBITDA - Capex)	-0.42	-0.14	0.93	0.19	-0.06
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-96.6	148.46	-
Gross Profit, 1 Yr. Growth %	-	-184.42	-191.86	6.66	15.99
EBITDA, 1 Yr. Growth %	-	-156.47	-299.47	1.5	4.28
EBITA, 1 Yr. Growth %	-	-155.3	-301.64	1.59	4.45
EBIT, 1 Yr. Growth %	-	-155.3	-301.64	1.59	4.45
Earnings From Cont. Operations, 1 Yr. Growth %	-	-200.01	11.17	-243.47	58
Net Income, 1 Yr. Growth %	-	-101.17	9.42K	-243.47	58
Normalized Net Income, 1 Yr. Growth %	-	-73.4	312.39	6.65	2.95
Diluted EPS Before Extra, 1 Yr. Growth %	-	-100.95	290.68	-225.09	19
Net Property, Plant and Equip., 1 Yr. Growth %	-	-84.69	103.97	36.96	-45.17
Total Assets, 1 Yr. Growth %	-	227.85	223.61	-46.21	-29.35
Tangible Book Value, 1 Yr. Growth %	-	-10.08	-113.07	-77.46	-248.74
Common Equity, 1 Yr. Growth %	-	-10.08	-113.07	-77.46	-248.74
Cash From Operations, 1 Yr. Growth %	-	-150.13	-279.89	4.06	14.1
Capital Expenditures, 1 Yr. Growth %	-	3.75K	-72.73	357.14	-49.48
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-260.88	7.62	26.19
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-233.58	5.78	25.81
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-	-70.91	-
Gross Profit, 2 Yr. CAGR %	-	-	-11.94	-1.02	11.23
EBITDA, 2 Yr. CAGR %	-	-	6.13	42.29	2.88
EBITA, 2 Yr. CAGR %	-	-	5.6	43.12	3.01
EBIT, 2 Yr. CAGR %	-	-	5.6	43.12	3.01
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	5.44	26.29	50.56
Net Income, 2 Yr. CAGR %	-	-	5.44	1.07K	50.56
Normalized Net Income, 2 Yr. CAGR %	-	-	4.73	109.72	4.79
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-80.76	121.07	22.01
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-44.12	67.14	-13.34
Total Assets, 2 Yr. CAGR %	-	-	225.72	31.94	-38.35
Tangible Book Value, 2 Yr. CAGR %	-	-	-65.72	-82.84	-42.1
Common Equity, 2 Yr. CAGR %	-	-	-65.72	-82.84	-42.1
Cash From Operations, 2 Yr. CAGR %	-	-	-5.04	36.82	8.96
Capital Expenditures, 2 Yr. CAGR %	-	-	224.04	11.66	51.97
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	31.58	16.54
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	18.87	15.36
Compound Annual Growth Rate Over Three Years
Gross Profit, 3 Yr. CAGR %	-	-	-	-6.13	4.35
EBITDA, 3 Yr. CAGR %	-	-	-	4.56	28.28
EBITA, 3 Yr. CAGR %	-	-	-	4.24	28.85
EBIT, 3 Yr. CAGR %	-	-	-	4.24	28.85
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	16.84	36.08
Net Income, 3 Yr. CAGR %	-	-	-	16.84	499.75
Normalized Net Income, 3 Yr. CAGR %	-	-	-	5.37	65.44
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-64.09	79.83
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	-24.66	15.27
Total Assets, 3 Yr. CAGR %	-	-	-	78.7	7.14
Tangible Book Value, 3 Yr. CAGR %	-	-	-	-70.19	-64.74
Common Equity, 3 Yr. CAGR %	-	-	-	-70.19	-64.74
Cash From Operations, 3 Yr. CAGR %	-	-	-	-2.1	28.78
Capital Expenditures, 3 Yr. CAGR %	-	-	-	263.42	-14.28
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	29.76
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	21.14